J Korean Diabetes Assoc.  2006 May;30(3):190-197. 10.4093/jkda.2006.30.3.190.

The Clinical Characteristics of Young Onset Diabetes According to Etiology Based Classification

Affiliations
  • 1Department of Endocrinology and Metabolism, College of Medicine, Kyung Hee University, Korea.
  • 2Endocrine Research Institute, College of Medicine, Kyung Hee University, Korea.

Abstract

BACKGROUND: Recently, the number of young diabetic patients is increasing. It is important to understand the characteristics of young diabetes and classify it correctly to manage these patients successfully. We aimed to classify young onset diabetes according to etiology and evaluate the clinical characteristics.
METHODS
Young patients (15~30 years old) who have been treated diabetes in Kyunghee medical center in 2004 were included. We investigated family history of diabetes, disease duration, body mass index (BMI), the history of diabetic ketoacidosis, HbA1c, fasting C-peptide, autoantibody, lipid profile and treatment method via medical records. RESULT: Total 85 patients (M:F 40:45) were evaluated. Type 1 diabetes was 45.9%, type 2 diabetes was 23.5% and unclassified group was 25.9%. Many type 2 diabetic patients were overweight or obese (94.8%). Most young diabetic patients were using insulin (95.4%). Many type 1 diabetic patients have been treated by insulin only and many type 2 diabetic patients have been received combined therapy of insulin and oral hypoglycemic agent. The recent HbA1c was average 8.32 +/- 2.7%. The prevalence of diabetic retinopathy, neuropathy and nephropathy was 32.9%, 22.4% and 16.4% as each.
CONCLUSION
Nearly half of young onset diabetes was type 1 diabetes but many others were also classified to type 2 diabetes or unclassified group. It is important to provide a consistent algorithm for assessment and investigation for newly diagnosed young diabetic patients. More education and effort are required to control diabetes strictly and prevent its complication.

Keyword

Autoantibody; C-peptide; Type 1 diabetes; Type 2 diabetes

MeSH Terms

Body Mass Index
C-Peptide
Classification*
Diabetic Ketoacidosis
Diabetic Retinopathy
Education
Fasting
Humans
Insulin
Medical Records
Overweight
Prevalence
C-Peptide
Insulin

Cited by  1 articles

2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association
Jun Sung Moon, Shinae Kang, Jong Han Choi, Kyung Ae Lee, Joon Ho Moon, Suk Chon, Dae Jung Kim, Hyun Jin Kim, Ji A Seo, Mee Kyoung Kim, Jeong Hyun Lim, Yoon Ju Song, Ye Seul Yang, Jae Hyeon Kim, You-Bin Lee, Junghyun Noh, Kyu Yeon Hur, Jong Suk Park, Sang Youl Rhee, Hae Jin Kim, Hyun Min Kim, Jung Hae Ko, Nam Hoon Kim, Chong Hwa Kim, Jeeyun Ahn, Tae Jung Oh, Soo-Kyung Kim, Jaehyun Kim, Eugene Han, Sang-Man Jin, Jaehyun Bae, Eonju Jeon, Ji Min Kim, Seon Mee Kang, Jung Hwan Park, Jae-Seung Yun, Bong-Soo Cha, Min Kyong Moon, Byung-Wan Lee
Diabetes Metab J. 2024;48(4):546-708.    doi: 10.4093/dmj.2024.0249.


Reference

1. National Diabetes Data Group. Classification and Diagnosis of Diabetes Mellitus and other categories of glucose intolerance. Diabetes. 1979. 28:1039–1057.
2. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997. 20:1183–1197.
3. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. 1999. Geneva: World Health Organization.
4. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001. 414:782–787.
5. Ahn CW, Kim HS, Nam JH, Song YD, Lim SK, Kim KR, Lee HC, Huh KB. Clinical characteristics, GAD antibody(GADA) and change of c-peptide in Korean young age of onset diabetic patients. Diabet Med. 2002. 19:227–233.
6. Porter JR, Barrett TG. Acquired non-type 1 diabetes in childhood: subtypes, diagnosis, and management. Arch Dis Child. 2004. 89:1138–1144.
7. Ehtisham S, Hattersley AT, Dunger DB, Barrett TG. First UK survey of pediatric type 2 diabetes and MODY. Arch Dis Child. 2004. 89:526–529.
13. Borg H, Arnqvist HJ, Bjork E, Bolinder J, Eriksson JW, Nystrom L, Jeppson JO, Sundkvist G. Evaluation of the new ADA and WHO criteria for classification of diabetes mellitus in young adult people (15-34 yrs) in the Diabetes Incidence Study in Sweden(DISS). Diabetologia. 2003. 46:173–181.
14. Lee KU, Kim SW, Park JY, Ko KS, Rhee BD, Min HK. Clinical heterogeneity of insulin dependent diabetes mellitus in Korea. Diabetes Res Clin Prac. 1995. 27:159–162.
20. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non insulin dependent onset of diabetes. Diabetes. 1993. 42:359–362.
21. Lee HC, Kim DH, Nam JH, Ahn CW, Lim SK, Huh KB, Nam SY, Park SW, Song YD, Kim HS, Kweon JW, Chang KH, Kim KR. Follow up study of clinical and immunologic characteristics and basal c-peptide in Korea young age onset diabetic patients. J Korean Diabetes Asso. 1999. 23:288–298.
Full Text Links
  • JKDA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr